Categories: HealthcareNews

Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025

CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its third quarter 2025 financial results after market close on Thursday, November 6, 2025. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.

Conference Call Information

To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call.

Event Date: Thursday, November 6, 2025
Time: 1:30 PM Pacific Time

Participant Registration: https://register-conf.media-server.com/register/BI1ecfe408f669412a83420306dedf3952

A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company’s website here.

About Carlsmed

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
IR@Carlsmed.com

Media

LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com

Staff

Recent Posts

Atropos Health Expands Oncology Precision Medicine Capabilities with Publication of New AI Algorithms for Rare Disease and Integration of ASCO Guidelines

Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…

1 hour ago

USF and Old Dominion to Play in the 2025 StaffDNA Cure Bowl

PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…

1 hour ago

The Dot Corp Expands Services With New Promotional Products & Apparel Division

IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…

1 hour ago

Vaniam Group Launches Predictive Pathways: A New Capability for Anticipating Market-Shaping Signals

CHICAGO, Dec. 5, 2025 /PRNewswire/ -- Vaniam Group™, a category leader redefining medical communications, announced…

1 hour ago

Biorep Technologies Announces First Successful Independent Research Use of the PRISM System in Islet Isolation

Results confirm reproducibility and research readiness for islet isolation of Biorep's next generation laboratory platform.MIAMI,…

1 hour ago